12th Mar 2018 17:49
The placing will be conducted by an accelerated bookbuild jointly-run by Jefferies International Ltd and Peel Hunt LLP.
The exact number of shares, and the price at which they will be placed, will be determined at the closing of the bookbuild.
PureTech Health said the proceeds will go towards funding the development of its growth-stage affiliates focused on the brain-immune-gut axis. Also, the company will invest in advancing its next generation of internally-funded immune focused programmes.
PureTech Health shares closed down 2.7% at
Related Shares:
PureTech